Ligand profile
FTP
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_3099 — thiamine-phosphate pyrophosphorylase
Identifiers
Database identifiers and provenance.
- Ligand ID
FTP- PDB
1g4t- UniProt (similar protein)
P39594- Target protein
- VK055_3099
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 128.1
- −1 ≤ LogP ≤ 5 0.17
- MW ≤ 500 Da 397.3
- LogP ≤ 5 0.17
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 128.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c(sc[n+]1Cc2cnc(nc2N)C(F)(F)F)CCOP(=O)([O-])[O-]Cc1c(sc[n+]1Cc2cnc(nc2N)C(F)(F)F)CCOP(=O)([O-])[O-]
InChI=1S/C12H14F3N4O4PS/c1-7-9(2-3-23-24(20,21)22)25-6-19(7)5-8-4-17-11(12(13,14)15)18-10(8)16/h4,6H,2-3,5H2,1H3,(H3-,16,17,18,20,21,22)/p-1InChI=1S/C12H14F3N4O4PS/c1-7-9(2-3-23-24(20,21)22)25-6-19(7)5-8-4-17-11(12(13,14)15)18-10(8)16/h4,6H,2-3,5H2,1H3,(H3-,16,17,18,20,21,22)/p-1
ZIBIECXVPMYJCV-UHFFFAOYSA-MZIBIECXVPMYJCV-UHFFFAOYSA-M
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02581
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand FTP →
- PDB RCSB structure 1g4t →
- UniProt UniProt P39594 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “FTP”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3099.
PDB 9
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).